Review: could Rebif cause Muscle spasticity?
Summary: Muscle spasticity is found among people who take Rebif, especially for people who are female, 40-49 old, have been taking the drug for 2 - 5 years, also take medication Baclofen, and have Multiple sclerosis.
We study 32,036 people who have side effects while taking Rebif from FDA and social media. Among them, 153 have Muscle spasticity. Find out below who they are, when they have Muscle spasticity and more.
You are not alone: join a support group for people who take Rebif and have Muscle spasticity >>>
Rebif has active ingredients of interferon beta-1a. It is often used in multiple sclerosis. (latest outcomes from 32,159 Rebif users)
Muscle spasticity (tight or stiff muscles and an inability to control those muscles) has been reported by people with multiple sclerosis, depression, pain, relapsing-remitting multiple sclerosis, stress and anxiety. (latest reports from 14,904 Muscle spasticity patients)
On Mar, 27, 2015: 32,036 people reported to have side effects when taking Rebif. Among them, 153 people (0.48%) have Muscle Spasticity.
Time on Rebif when people have Muscle spasticity * :
|< 1 month||1 - 6 months||6 - 12 months||1 - 2 years||2 - 5 years||5 - 10 years||10+ years |
|Muscle spasticity||8.70%||15.22%||10.87%||17.39%||36.96%||6.52%||4.35% |
Gender of people who have Muscle spasticity when taking Rebif * :
|Muscle spasticity||76.57%||23.43% |
Age of people who have Muscle spasticity when taking Rebif * :
|Muscle spasticity||0.00%||0.00%||0.66%||8.55%||24.34%||25.00%||25.00%||16.45% |
Severity of Muscle spasticity when taking Rebif ** :
How people recovered from Muscle spasticity ** :
Top conditions involved for these people * :
- Multiple sclerosis (125 people, 81.70%)
- Relapsing-remitting multiple sclerosis (15 people, 9.80%)
- Depression (8 people, 5.23%)
- Pain (6 people, 3.92%)
- Secondary progressive multiple sclerosis (5 people, 3.27%)
Top co-used drugs for these people * :
- Baclofen (32 people, 20.92%)
- Ibuprofen (12 people, 7.84%)
- Amantadine hcl (10 people, 6.54%)
- Neurontin (9 people, 5.88%)
- Provigil (8 people, 5.23%)
* Approximation only. Some reports may have incomplete information.
** Reports from social media are used.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Do you have Muscle Spasticity while taking Rebif?
You are not alone! Join a support group on :
- support group for people who take Rebif and have Muscle Spasticity
- support group for people who take Rebif
- support group for people who have Muscle Spasticity
Drugs in real world that are associated with:
Could your condition cause:
- A study of side effects of Rebif for a 20-year old woman with Multiple Sclerosis. The patient has Intranasal Numbness
- A study of drug interactions between Relafen, Neurontin, Flexeril, Humira for a 51-year old man with Autoimmune Disorder. The patient has Muscle Spasticity, Peripheral Neuropathy, Cervical Spine Pain
- A study of drug interactions between Rebif, Keflex for a 36-year old woman with MS, Sinusitis.
- A study of drug interactions between Rebif, Sovaldi for a 59-year old man with Viral Hepatitis. The patient has Burning Eyes
- A study of drug interactions between Sulfasalazine, Oxybutynin Chloride, Simvastatin, Lorazepam, Sertraline, Metoprolol Tartrate, Levothyroxine Sodium, Hydroxychloroquine Sulfate, Lyrica, Rebif for a 62-year old woman with Rheumatoid Arthritis, Bladder Spasm, High Blood Cholesterol, Anxiety, Mood Stabilizer, High Blood Pressure, Hypothyroidism, Multiple Sclerosis Relapse.
Recent Rebif related drug comparison:
NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.